FDA NDC Directory · JSON-LD · Markdown

LETROZOLE

NDC 50268-476 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA200161
Dosage form / routeTABLET · ORAL
Active ingredientsLETROZOLE (2.5 mg/1)
Marketing started20191002
Package count1

External sources

Source: openFDA. Public-domain (CC0).